Letizia Foroni

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications

The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.

The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.

Journal: British journal of haematology
Published: October 15, 2021

Assessment of quantitative polymerase chain reaction for BCR-ABL1 transcripts in chronic myeloid leukaemia: Are improved outcomes in patients with e14a2 transcripts an artefact of technology?

Assessment of quantitative polymerase chain reaction for BCR-ABL1 transcripts in chronic myeloid leukaemia: Are improved outcomes in patients with e14a2 transcripts an artefact of technology?

Journal: British journal of haematology
Published: September 05, 2021

Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.

Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.

Journal: Blood
Published: November 27, 2020

TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia.

TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia.

Journal: British journal of haematology
Published: September 05, 2020

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.

Journal: Blood
Published: May 14, 2020

A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia.

A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia.

Journal: British journal of haematology
Published: April 24, 2020

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.

Journal: British journal of haematology
Published: December 18, 2019

Serotonin re-uptake transporter gene polymorphisms are associated with imatinib-induced diarrhoea in chronic myeloid leukaemia patients.

Serotonin re-uptake transporter gene polymorphisms are associated with imatinib-induced diarrhoea in chronic myeloid leukaemia patients.

Journal: Scientific reports
Published: September 15, 2019

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease.

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease.

Journal: Leukemia
Published: August 08, 2019

In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent.

In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent.

Journal: Leukemia
Published: July 10, 2019

MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia.

MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia.

Journal: Haematologica
Published: December 16, 2018

Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?

Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?

Journal: Oncotarget
Published: December 02, 2018
Showing 1-12 of 54

Last Updated: 09/26/2026